Indian Drug Firms
-
Maiden Pharmaceuticals responsible for the deaths of 66 children, says Gambia Parliamentary panel
The select committee recommended that the Indian medicine manufacturer should be blacklisted and its products be banned in West African nation.
Scroll Staff
-
Maiden Pharma seeks to reopen factory after drug regulator says no contaminants in cough syrups
On Tuesday, the DCGI said that the WHO drew a premature link between the deaths of 66 children in The Gambia and the cough syrups made by Haryana-based company.
Scroll Staff
-
WHO drew premature link between deaths of children in Gambia and India-made cough syrups, says DCGI
Test reports have shown that the syrups were not contaminated with diethylene glycol or ethylene glycol, the drug regulator said.
Scroll Staff
Trending
-
India is now the world’s most populous nation – but there’s no reason to be worried
-
Journalist Nidhi Razdan quits NDTV
-
IND vs NZ: Reactions as Shubman Gill scores his first T20I century – ‘Unreal, smooth, clean striking
-
Aaj Tak says its anchors will report on Budget 2023 suspended from a tower at a height of 160 feet
-
Watch: Bengaluru waiter effortlessly carries 16 plates of dosa, serves several customers at once
-
Haryana stops production of cough syrups linked to deaths of 66 children in The Gambia
State health minister said that 12 flaws were found during an inspection of the medicines and their manufacturing process.
Scroll Staff
-
Gambia Police begin probe into deaths of children linked to India-made cough syrups
President Adama Barrow’s office said that the foreign ministry had been asked to communicate the government’s ‘most profound concern’ to the Indian embassy.
Scroll Staff
-
Firm linked to Gambia deaths failed to meet standards for other drugs four times in India this year
Meanwhile, the Food and Drug Administration in Haryana said it was preparing to test samples of the four syrups, which were made for export.
Tabassum Barnagarwala
Video
-
Watch: Bystander, police officer rescue driver moments before crashed car bursts into flames
-
Watch: Bengaluru waiter effortlessly carries 16 plates of dosa, serves several customers at once
-
Watch: Pakistani TV anchors are stunned by Athiya Shetty and KL Rahul’s lavish wedding gifts
-
Watch: McDonald’s first automated outlet is open for business in Texas, US
-
Watch: Woman caught on camera shoplifting in a bookstore in Jalandhar, Punjab
-
Thalassemia patients complain of shortage of life-saving drug that removes excess iron from blood
However, Novartis, the sole manufacturer of the medicine, says that the stock is sufficient.
Priyanka Vora
-
Is 74% foreign direct investment in brownfield pharma really bad for Indian generics?
The new policy can keep Indian companies competitive and bring investment into the country.
Prashant Reddy